Lilly Says Higher-Dose Zepbound Just Widened Its Lead Over Wegovy
Eli Lilly (LLY, Financials) says higher doses of Zepbound may have widened its weight-loss advantage over Novo Nordisk's Wegovy.A new indirect analysis found that patients receiving Zepbound 15 mg and 10 mg had 4.5 percentage points and 3.2 percentage points more weight loss, respectively, over 72…